Clinical Trial Update: A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC

View source ↗

Summary

This prospective, multicenter, non-interventional real-world study will characterize changes in molecular markers after three weeks of targeted Oxitinib therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Oxitinib (Oxitinib)

Snippet

Sponsor: Beijing Cancer Prevention & Treatment Society | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING